Towards the Sixth Framework Programme

1
Towards the Sixth Framework Programme
Parallel Forum V 26 September 2002 Public Health
Research for European Community Policies Dr . O.
Quintana Trias, DG RTD European Commission
2
Bottlenecks-European research

• Fragmentation and heterogeneity
• Under-resourcing
• Environment less favourableto exploitation

3
A fundamental reassessment ...

• to exert a more structuring effect
• to combine FP funding to a greater extent with
  other public private sector funding
• to link Framework Programmes more closely with
  national and European intergovernmental
  activities
• European added value

4
European Research Area

• Five major keys
• Critical mass financial / material / human
  resources
• ? Mobility of researchers / engineers /
  technicians
• ? Make Europe attractive to best scientists
• ? Favourable research and innovation environment
  IPR, encourage academia / industry
  partnerships
• ? Increase RTD investment to up to 3 of GDP
  (public private)

5
6th Framework Programme a tool

• Greater concentration
• ? Limited number of priorities of
  strategic importance for EU
• ? Where EU action can add greatest value

• More effective instruments

• Simplified implementation
• ? Longer term projects
• ? Increased flexibility
• ? Increased autonomy

6
Integrating European Research 7 Priority Themes
Proposed budget (millions ) 1. Genomics and
biotechnology for health 2200 2.
Information society technologies 3600 3.
Nanotechnologies, 1300 4. Aeronautics and
space 1075 5. Food safety and health risks
685 6. Sustainable development and global
change 2120 7. Citizens and governance in the
knowledge society 225
7
Public Health and the 6 FP (i)

• 1.1 Genomes and biotechnology for health
• 1.2 Information society technologies
• 1.5 Food quality and safety

8
Public Health and the 6 FP (ii)

• Priority 8
• 1.2.1 Specific activities covering a
  wider field of research (1.2)
• Supporting policies and anticipating
  scientific and technological needs (1.2.1)
• 2. Strengthening the ERA foundations

9
1.1.1 Genomics

• 1.1.1.1 Advanced genomics - applications for
  health
• Fundamental knowledge and basic tools for
  functional genomics in all organisms gene
  expression and proteomics, structural genomics,
  bioinformatics, etc.
• Application of knowledge and technologies in
  genomics and biotechnology for health
  technological platforms, prevention and
  therapeutic tools, etc.
• 1.1.1.2 Combating major diseases
• Application-oriented genomic approaches to
  medical knowledge and technologies diabetes,
  cardiovascular diseases, resistance to
  antibiotics, brain and ageing, etc.
• Cancer
• Major poverty-linked infectious diseases aids,
  malaria and tuberculosis

10
1.1.1 Genomics

• 1.1.1.2 Combating major diseases
• 1.1.1.2.1 Applications in medicine public
  health
• cardiovascular disease, diabetes, rare
  diseases
• integrating clinical expertise and resources with
  relevant model systems and advanced tools in
  functional genomics gtgt breakthroughs in
  prevention and disease management
• pool Europes research resources to tackle rare
  diseases
• resistance to antibiotics drugs
• exploitation of knowledge of microbial genomes
  and host-pathogen interactions gtgt vaccines,
  alternative strategies
• strategies for optimal use of antimicrobials
• support EC network on epidemiological
  surveillance andcontrol of communicable diseases

11
1.1.1 Genomics

• 1.1.1.2 Combating major diseases
• 1.1.1.2.1 Applications in medicine public
  health
• studying the brain and combating diseases of the
  nervous system
• Understanding molecular / cellular bases of
  brain function, damage, plasticity and repair,
  learning, memory, cognition
• Developing prevention and management strategies
  of neurological and mental disorders and
  diseases
• studying human development and the ageing
  process
• Human development from conception to adolescence
• Molecular and cellular determinants of healthy
  ageing, including interaction with
  environmental, behavioural, gender factors

12
1.1.1 Genomics

• 1.1.1.2 Combating major diseases
• 1.1.1.2.2 Combating cancer
• Establishing facilities for exploitation of
  research
• Development of evidence-based guidelines for
  good clinical practice and improved public
  health strategies
• Accelerate translation of existing research
  results into applications
• Supporting clinical research / clinical trials
• Aim validation of new and improved
  interventions
• Supporting translational research
• Aim bringing basic knowledge through to
  applications in clinical practice and public
  health

13
1.1.1 Genomics

• 1.1.1.2 Combating major diseases
• 1.1.1.2.3 Confronting major communicable
  diseases linked to poverty - a broader
  approach
• Developing candidate interventions
• Vaccines, therapies and HIV microbiocides
  against HIV/AIDS, malaria, tuberculosis through
  basic molecular research, taking advantage of
  microbial genomics, pre-clinical testing,
  proof-of-principle
• Establishing a clinical trials programme
• Aim support Europes clinical trials
  activities targeted at interventions for use in
  developing countries
• Establishing an AIDS Therapy Trials Network
• Aim improve coherence and complementarity of
  clinical trials on AIDS therapies

14
Information

• General information on research
  http//europa.eu.int/comm/research
• General information on the Sixth Framework
  Programme http//europa.eu.int/comm/research/nf
  p.html
• Information on research programmes and projects
• http//www.cordis.lu
• Information requests
• research_at_cec.eu.int